Afsaneh Shirani, MD, MSCI
Afsaneh Shirani, MD, MSCI
Verified email at unmc.edu
TitleCited byYear
Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis
A Shirani, Y Zhao, ME Karim, C Evans, E Kingwell, ML Van Der Kop, ...
Jama 308 (3), 247-256, 2012
2872012
Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada
E Kingwell, M Van der Kop, Y Zhao, A Shirani, F Zhu, J Oger, H Tremlett
J Neurol Neurosurg Psychiatry 83 (1), 61-66, 2012
1182012
Outcomes and recurrence rates in chronic subdural haematoma
A Amirjamshidi, M Abouzari, B Eftekhar, A Rashidi, J Rezaii, K Esfandiari, ...
British journal of neurosurgery 21 (3), 272-275, 2007
892007
Antimicrobial resistance pattern of Gram-negative bacilli of nosocomial origin at 2 university hospitals in Iran
A Hadadi, M Rasoulinejad, Z Maleki, M Yonesian, A Shirani, Z Kourorian
Diagnostic microbiology and infectious disease 60 (3), 301-305, 2008
742008
Therapeutic advances and future prospects in progressive forms of multiple sclerosis
A Shirani, DT Okuda, O Stüve
Neurotherapeutics 13 (1), 58-69, 2016
672016
Characterising aggressive multiple sclerosis
S Menon, A Shirani, Y Zhao, J Oger, A Traboulsee, MS Freedman, ...
J Neurol Neurosurg Psychiatry 84 (11), 1192-1198, 2013
672013
Oligoclonal bands and cerebrospinal fluid markers in multiple sclerosis: associations with disease course and progression
P Lourenco, A Shirani, J Saeedi, J Oger, WE Schreiber, H Tremlett
Multiple Sclerosis Journal 19 (5), 577-584, 2013
522013
Temporal trends of disability progression in multiple sclerosis: findings from British Columbia, Canada (1975–2009)
A Shirani, Y Zhao, E Kingwell, P Rieckmann, H Tremlett
Multiple Sclerosis Journal 18 (4), 442-450, 2012
402012
Marginal structural Cox models for estimating the association between β-interferon exposure and disease progression in a multiple sclerosis cohort
ME Karim, P Gustafson, J Petkau, Y Zhao, A Shirani, E Kingwell, C Evans, ...
American journal of epidemiology 180 (2), 160-171, 2014
332014
Beta‐interferon exposure and onset of secondary progressive multiple sclerosis
T Zhang, A Shirani, Y Zhao, ME Karim, P Gustafson, J Petkau, C Evans, ...
European journal of neurology 22 (6), 990-1000, 2015
242015
Effect of early interferon beta‐1a therapy on conversion to multiple sclerosis in Iranian patients with a first demyelinating event
H Pakdaman, MA Sahraian, A Fallah, R Pakdaman, K Ghareghozli, ...
Acta Neurologica Scandinavica 115 (6), 429-431, 2007
242007
Evaluating the safety of β-interferons in MS: A series of nested case-control studies
HJI De Jong, E Kingwell, A Shirani, JWC Tervaert, R Hupperts, Y Zhao, ...
Neurology 88 (24), 2310-2320, 2017
232017
Serum prolactin level in patients with multiple sclerosis: A case control study.
MH Harirchian, MA Sahraian, A Shirani
Medical science monitor 12 (4), CR177-CR180, 2006
232006
The effect of smoking on the symptoms and progression of multiple sclerosis: a review
A Shirani, H Tremlett
Journal of inflammation research 3, 115, 2010
212010
Multiple sclerosis in older adults: the clinical profile and impact of interferon beta treatment
A Shirani, Y Zhao, J Petkau, P Gustafson, ME Karim, C Evans, E Kingwell, ...
BioMed research international 2015, 2015
202015
Comparison of statistical approaches for dealing with immortal time bias in drug effectiveness studies
ME Karim, P Gustafson, J Petkau, H Tremlett, ...
American journal of epidemiology 184 (4), 325-335, 2016
142016
Investigation of heterogeneity in the association between interferon beta and disability progression in multiple sclerosis: an observational study
A Shirani, Y Zhao, ME Karim, J Petkau, P Gustafson, C Evans, E Kingwell, ...
European journal of neurology 21 (6), 835-844, 2014
122014
Association between beta‐interferon exposure and hospital events in multiple sclerosis
C Evans, F Zhu, E Kingwell, A Shirani, ML van der Kop, J Petkau, ...
Pharmacoepidemiology and drug safety 23 (11), 1213-1222, 2014
82014
Interferon beta and long-term disability in multiple sclerosis
A Shirani, Y Zhao, ME Karim, C Evans, E Kingwell, ML Van Der Kop, ...
JAMA neurology 70 (5), 651-653, 2013
72013
Finger tapping impairments are highly sensitive for evaluating upper motor neuron lesions
A Shirani, BD Newton, DT Okuda
BMC neurology 17 (1), 55, 2017
62017
The system can't perform the operation now. Try again later.
Articles 1–20